The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), ...
IonQ's strong revenue growth and partnerships with industry leaders are promising, but high operating expenses and reliance ...
Sir Chris Whitty tells the Covid-19 Inquiry the NHS has 'slipped backwards' since the pandemic at sharing vital patient data, ...
A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...
According to David Einhorn value investors have a problem with the way the stock market works at the moment. So what should they do?
There is less than a fortnight left for Northern Irish companies to enter this year’s MacRobert Award, the longest running and most prestigious annual prize for UK engineering innovation.
A study published in Nature Medicine looks at the health risks and benefits linked to GLP-1 receptor agonists. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University ...
Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...
MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...
There is less than a fortnight left for companies across Belfast to enter this year’s MacRobert Award, the longest running ...
Sachin Jain, an analyst from Bank of America Securities, reiterated the Buy rating on AstraZeneca (AZN – Research Report). The associated price ...